Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Enterprise Value (2020 - 2025)

Historic Enterprise Value for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to -$41.2 million.

  • Rapid Micro Biosystems' Enterprise Value rose 3219.36% to -$41.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.2 million, marking a year-over-year increase of 3219.36%. This contributed to the annual value of -$50.7 million for FY2024, which is 4488.83% up from last year.
  • Latest data reveals that Rapid Micro Biosystems reported Enterprise Value of -$41.2 million as of Q3 2025, which was up 3219.36% from -$31.3 million recorded in Q2 2025.
  • Over the past 5 years, Rapid Micro Biosystems' Enterprise Value peaked at -$31.3 million during Q2 2025, and registered a low of -$221.0 million during Q3 2021.
  • Over the past 5 years, Rapid Micro Biosystems' median Enterprise Value value was -$95.9 million (recorded in 2023), while the average stood at -$100.4 million.
  • As far as peak fluctuations go, Rapid Micro Biosystems' Enterprise Value tumbled by 32925.88% in 2021, and later soared by 5495.75% in 2025.
  • Rapid Micro Biosystems' Enterprise Value (Quarter) stood at -$193.5 million in 2021, then skyrocketed by 43.85% to -$108.6 million in 2022, then grew by 15.27% to -$92.1 million in 2023, then skyrocketed by 44.89% to -$50.7 million in 2024, then increased by 18.69% to -$41.2 million in 2025.
  • Its Enterprise Value was -$41.2 million in Q3 2025, compared to -$31.3 million in Q2 2025 and -$41.7 million in Q1 2025.